IBDEI0I7 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23073,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23073,1,2,0)
 ;;=2^S9453
 ;;^UTILITY(U,$J,358.3,23073,1,3,0)
 ;;=3^SMOKING CESSATION CLASS,NON-MD,PER SESSION
 ;;^UTILITY(U,$J,358.3,23074,0)
 ;;=S9454^^59^862^56^^^^1
 ;;^UTILITY(U,$J,358.3,23074,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23074,1,2,0)
 ;;=2^S9454
 ;;^UTILITY(U,$J,358.3,23074,1,3,0)
 ;;=3^STRESS MGMT CLASS,NON-MD,PER SESSION
 ;;^UTILITY(U,$J,358.3,23075,0)
 ;;=T1016^^59^862^9^^^^1
 ;;^UTILITY(U,$J,358.3,23075,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23075,1,2,0)
 ;;=2^T1016
 ;;^UTILITY(U,$J,358.3,23075,1,3,0)
 ;;=3^CASE MANAGEMENT,EA 15 MIN
 ;;^UTILITY(U,$J,358.3,23076,0)
 ;;=90889^^59^862^49^^^^1
 ;;^UTILITY(U,$J,358.3,23076,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23076,1,2,0)
 ;;=2^90889
 ;;^UTILITY(U,$J,358.3,23076,1,3,0)
 ;;=3^RPT PREPARATION FOR IND/AGENCY/INSURANCE
 ;;^UTILITY(U,$J,358.3,23077,0)
 ;;=S9449^^59^862^61^^^^1
 ;;^UTILITY(U,$J,358.3,23077,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23077,1,2,0)
 ;;=2^S9449
 ;;^UTILITY(U,$J,358.3,23077,1,3,0)
 ;;=3^WEIGHT MGMT CLASS,NON-MD,PER SESSION
 ;;^UTILITY(U,$J,358.3,23078,0)
 ;;=90791^^59^863^1^^^^1
 ;;^UTILITY(U,$J,358.3,23078,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23078,1,2,0)
 ;;=2^90791
 ;;^UTILITY(U,$J,358.3,23078,1,3,0)
 ;;=3^PSYCH DIAGNOSTIC EVALUATION
 ;;^UTILITY(U,$J,358.3,23079,0)
 ;;=90792^^59^863^2^^^^1
 ;;^UTILITY(U,$J,358.3,23079,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23079,1,2,0)
 ;;=2^90792
 ;;^UTILITY(U,$J,358.3,23079,1,3,0)
 ;;=3^PSYCH DIAGNOSTIC EVAL W/ MEDICAL SERVICES
 ;;^UTILITY(U,$J,358.3,23080,0)
 ;;=90847^^59^864^1^^^^1
 ;;^UTILITY(U,$J,358.3,23080,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23080,1,2,0)
 ;;=2^90847
 ;;^UTILITY(U,$J,358.3,23080,1,3,0)
 ;;=3^FAMILY PSYTX W/ PATIENT
 ;;^UTILITY(U,$J,358.3,23081,0)
 ;;=90849^^59^864^4^^^^1
 ;;^UTILITY(U,$J,358.3,23081,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23081,1,2,0)
 ;;=2^90849
 ;;^UTILITY(U,$J,358.3,23081,1,3,0)
 ;;=3^MULTIPLE FAMILY GROUP PSYTX
 ;;^UTILITY(U,$J,358.3,23082,0)
 ;;=90853^^59^864^3^^^^1
 ;;^UTILITY(U,$J,358.3,23082,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23082,1,2,0)
 ;;=2^90853
 ;;^UTILITY(U,$J,358.3,23082,1,3,0)
 ;;=3^GROUP PSYCHOTHERAPY
 ;;^UTILITY(U,$J,358.3,23083,0)
 ;;=90846^^59^864^2^^^^1
 ;;^UTILITY(U,$J,358.3,23083,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23083,1,2,0)
 ;;=2^90846
 ;;^UTILITY(U,$J,358.3,23083,1,3,0)
 ;;=3^FAMILY PSYTX W/O PATIENT
 ;;^UTILITY(U,$J,358.3,23084,0)
 ;;=90875^^59^865^3^^^^1
 ;;^UTILITY(U,$J,358.3,23084,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23084,1,2,0)
 ;;=2^90875
 ;;^UTILITY(U,$J,358.3,23084,1,3,0)
 ;;=3^IND PSYCHOSOC TX W/BIOFEEDBACK,30MIN
 ;;^UTILITY(U,$J,358.3,23085,0)
 ;;=90876^^59^865^4^^^^1
 ;;^UTILITY(U,$J,358.3,23085,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23085,1,2,0)
 ;;=2^90876
 ;;^UTILITY(U,$J,358.3,23085,1,3,0)
 ;;=3^IND PSYCHOSOC TX W/BIOFEEDBACK,45MIN
 ;;^UTILITY(U,$J,358.3,23086,0)
 ;;=90901^^59^865^5^^^^1
 ;;^UTILITY(U,$J,358.3,23086,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23086,1,2,0)
 ;;=2^90901
 ;;^UTILITY(U,$J,358.3,23086,1,3,0)
 ;;=3^BIOFEEDBACK TRAIN ANY METHOD
 ;;^UTILITY(U,$J,358.3,23087,0)
 ;;=90911^^59^865^6^^^^1
 ;;^UTILITY(U,$J,358.3,23087,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23087,1,2,0)
 ;;=2^90911
 ;;^UTILITY(U,$J,358.3,23087,1,3,0)
 ;;=3^BIOFEEDBACK PERI/URO/RECTAL
 ;;^UTILITY(U,$J,358.3,23088,0)
 ;;=T1016^^59^866^1^^^^1
 ;;^UTILITY(U,$J,358.3,23088,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23088,1,2,0)
 ;;=2^T1016
 ;;^UTILITY(U,$J,358.3,23088,1,3,0)
 ;;=3^CASE MGMT PER 15 MIN
 ;;^UTILITY(U,$J,358.3,23089,0)
 ;;=99600^^59^866^2^^^^1
 ;;^UTILITY(U,$J,358.3,23089,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23089,1,2,0)
 ;;=2^99600
 ;;^UTILITY(U,$J,358.3,23089,1,3,0)
 ;;=3^CASE MGMT IN PT HOME
 ;;^UTILITY(U,$J,358.3,23090,0)
 ;;=90832^^59^867^1^^^^1
 ;;^UTILITY(U,$J,358.3,23090,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23090,1,2,0)
 ;;=2^90832
 ;;^UTILITY(U,$J,358.3,23090,1,3,0)
 ;;=3^PSYTX PT/FAM 16-37 MIN
 ;;^UTILITY(U,$J,358.3,23091,0)
 ;;=90834^^59^867^2^^^^1
 ;;^UTILITY(U,$J,358.3,23091,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23091,1,2,0)
 ;;=2^90834
 ;;^UTILITY(U,$J,358.3,23091,1,3,0)
 ;;=3^PSYTX PT/FAM 38-52 MIN
 ;;^UTILITY(U,$J,358.3,23092,0)
 ;;=90837^^59^867^3^^^^1
 ;;^UTILITY(U,$J,358.3,23092,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23092,1,2,0)
 ;;=2^90837
 ;;^UTILITY(U,$J,358.3,23092,1,3,0)
 ;;=3^PSYTX PT/FAM 53-89 MIN
 ;;^UTILITY(U,$J,358.3,23093,0)
 ;;=90785^^59^868^1^^^^1
 ;;^UTILITY(U,$J,358.3,23093,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23093,1,2,0)
 ;;=2^90785
 ;;^UTILITY(U,$J,358.3,23093,1,3,0)
 ;;=3^PSYTX INTERACTIVE COMPLEXITY
 ;;^UTILITY(U,$J,358.3,23094,0)
 ;;=90833^^59^869^1^^^^1
 ;;^UTILITY(U,$J,358.3,23094,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23094,1,2,0)
 ;;=2^90833
 ;;^UTILITY(U,$J,358.3,23094,1,3,0)
 ;;=3^PSYTX PT/FAM 16-37 MIN-REPORT W/ E&M CODE
 ;;^UTILITY(U,$J,358.3,23095,0)
 ;;=90836^^59^869^2^^^^1
 ;;^UTILITY(U,$J,358.3,23095,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23095,1,2,0)
 ;;=2^90836
 ;;^UTILITY(U,$J,358.3,23095,1,3,0)
 ;;=3^PSYTX PT/FAM 38-52 MIN-REPORT W/ E&M CODE
 ;;^UTILITY(U,$J,358.3,23096,0)
 ;;=90838^^59^869^3^^^^1
 ;;^UTILITY(U,$J,358.3,23096,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23096,1,2,0)
 ;;=2^90838
 ;;^UTILITY(U,$J,358.3,23096,1,3,0)
 ;;=3^PSYTX PT/FAM 53-89 MIN-REPORT W/ E&M CODE
 ;;^UTILITY(U,$J,358.3,23097,0)
 ;;=90839^^59^870^1^^^^1
 ;;^UTILITY(U,$J,358.3,23097,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23097,1,2,0)
 ;;=2^90839
 ;;^UTILITY(U,$J,358.3,23097,1,3,0)
 ;;=3^PSYTX CRISIS INITIAL 30-74 MIN
 ;;^UTILITY(U,$J,358.3,23098,0)
 ;;=90840^^59^870^2^^^^1
 ;;^UTILITY(U,$J,358.3,23098,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23098,1,2,0)
 ;;=2^90840
 ;;^UTILITY(U,$J,358.3,23098,1,3,0)
 ;;=3^PSYTX CRISIS EA ADDL 30 MIN
 ;;^UTILITY(U,$J,358.3,23099,0)
 ;;=99354^^59^871^3^^^^1
 ;;^UTILITY(U,$J,358.3,23099,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23099,1,2,0)
 ;;=2^99354
 ;;^UTILITY(U,$J,358.3,23099,1,3,0)
 ;;=3^PROLONGED SVC,OTPT,1ST HR
 ;;^UTILITY(U,$J,358.3,23100,0)
 ;;=99355^^59^871^4^^^^1
 ;;^UTILITY(U,$J,358.3,23100,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23100,1,2,0)
 ;;=2^99355
 ;;^UTILITY(U,$J,358.3,23100,1,3,0)
 ;;=3^PROLONGED SVC,OTPT,EA ADDL 30MIN
 ;;^UTILITY(U,$J,358.3,23101,0)
 ;;=99356^^59^871^1^^^^1
 ;;^UTILITY(U,$J,358.3,23101,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23101,1,2,0)
 ;;=2^99356
 ;;^UTILITY(U,$J,358.3,23101,1,3,0)
 ;;=3^PROLONGED SVC,INPT/OBS,1ST HR
 ;;^UTILITY(U,$J,358.3,23102,0)
 ;;=99357^^59^871^2^^^^1
 ;;^UTILITY(U,$J,358.3,23102,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23102,1,2,0)
 ;;=2^99357
 ;;^UTILITY(U,$J,358.3,23102,1,3,0)
 ;;=3^PROLONGED SVC,INPT/OBS,EA ADDL 30MIN
 ;;^UTILITY(U,$J,358.3,23103,0)
 ;;=90656^^59^872^2^^^^1
 ;;^UTILITY(U,$J,358.3,23103,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23103,1,2,0)
 ;;=2^90656
 ;;^UTILITY(U,$J,358.3,23103,1,3,0)
 ;;=3^FLU VACCINE,NO PRESERVATIVES,IM
 ;;^UTILITY(U,$J,358.3,23104,0)
 ;;=90658^^59^872^1^^^^1
 ;;^UTILITY(U,$J,358.3,23104,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23104,1,2,0)
 ;;=2^90658
 ;;^UTILITY(U,$J,358.3,23104,1,3,0)
 ;;=3^FLU VACCINE,IM
 ;;^UTILITY(U,$J,358.3,23105,0)
 ;;=J2680^^59^872^3^^^^1
 ;;^UTILITY(U,$J,358.3,23105,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23105,1,2,0)
 ;;=2^J2680
 ;;^UTILITY(U,$J,358.3,23105,1,3,0)
 ;;=3^FLUPHENAZINE DECANOATE Up To 25 MG
 ;;^UTILITY(U,$J,358.3,23106,0)
 ;;=J1631^^59^872^4^^^^1
 ;;^UTILITY(U,$J,358.3,23106,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23106,1,2,0)
 ;;=2^J1631
 ;;^UTILITY(U,$J,358.3,23106,1,3,0)
 ;;=3^HALOPERIDOL DECANOATE per 50MG
 ;;^UTILITY(U,$J,358.3,23107,0)
 ;;=J1050^^59^872^5^^^^1
 ;;^UTILITY(U,$J,358.3,23107,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23107,1,2,0)
 ;;=2^J1050
 ;;^UTILITY(U,$J,358.3,23107,1,3,0)
 ;;=3^MEDROXYPROGESTERONE ACETATE 1 MG
 ;;^UTILITY(U,$J,358.3,23108,0)
 ;;=J2315^^59^872^6^^^^1
 ;;^UTILITY(U,$J,358.3,23108,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23108,1,2,0)
 ;;=2^J2315
 ;;^UTILITY(U,$J,358.3,23108,1,3,0)
 ;;=3^NALTREXONE, DEPOT FORM 1 MG
 ;;^UTILITY(U,$J,358.3,23109,0)
 ;;=J2426^^59^872^7^^^^1
 ;;^UTILITY(U,$J,358.3,23109,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23109,1,2,0)
 ;;=2^J2426
 ;;^UTILITY(U,$J,358.3,23109,1,3,0)
 ;;=3^PALIPERIDONE PALMITATE EXTEND RELEASE 1 MG
 ;;^UTILITY(U,$J,358.3,23110,0)
 ;;=J2794^^59^872^9^^^^1
 ;;^UTILITY(U,$J,358.3,23110,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23110,1,2,0)
 ;;=2^J2794
 ;;^UTILITY(U,$J,358.3,23110,1,3,0)
 ;;=3^RISPERIDONE, LONG ACTING 0.5 MG
 ;;^UTILITY(U,$J,358.3,23111,0)
 ;;=J3420^^59^872^11^^^^1
 ;;^UTILITY(U,$J,358.3,23111,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23111,1,2,0)
 ;;=2^J3420
 ;;^UTILITY(U,$J,358.3,23111,1,3,0)
 ;;=3^VITAMIN B12 UP TO 1000 MCG
 ;;^UTILITY(U,$J,358.3,23112,0)
 ;;=90670^^59^872^8^^^^1
 ;;^UTILITY(U,$J,358.3,23112,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23112,1,2,0)
 ;;=2^90670
 ;;^UTILITY(U,$J,358.3,23112,1,3,0)
 ;;=3^PREVNAR 13 VACCINE IM
 ;;^UTILITY(U,$J,358.3,23113,0)
 ;;=86580^^59^872^10^^^^1
 ;;^UTILITY(U,$J,358.3,23113,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23113,1,2,0)
 ;;=2^86580
 ;;^UTILITY(U,$J,358.3,23113,1,3,0)
 ;;=3^TB INTRADERMAL TEST
 ;;^UTILITY(U,$J,358.3,23114,0)
 ;;=99411^^59^873^1^^^^1
 ;;^UTILITY(U,$J,358.3,23114,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23114,1,2,0)
 ;;=2^99411
 ;;^UTILITY(U,$J,358.3,23114,1,3,0)
 ;;=3^PREVENTIVE COUNSEL,GROUP,APPROX 30MIN
 ;;^UTILITY(U,$J,358.3,23115,0)
 ;;=99412^^59^873^2^^^^1
 ;;^UTILITY(U,$J,358.3,23115,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23115,1,2,0)
 ;;=2^99412
 ;;^UTILITY(U,$J,358.3,23115,1,3,0)
 ;;=3^PREVENTIVE COUNSEL,GROUP,APPROX 60MIN
